PLEASE NOTE: All events are in London (UK) time unless otherwise stated.

Loading Events

« All Events

  • This event has passed.

EphMRA 2021 Summer School: Market Access – South Korea and Columbia. What you need to know.

May 20, 2021 @ 3:00 pm 3:45 pm

Speakers: Ed Corbett and Alan Crowther, Eversana Management Consulting

Convenor: Bernadette Rogers, EphMRA

This webinar is aimed at those who want to learn more about doing market research in South Korea and Columbia. 

These markets have significant local nuances and you often need to think more creatively when designing your approach. 

Accessing key influencers and respondents such as HCPs, payors, and patients can be different to what you might be accustomed to in more frequently researched markets.  This webinar will give you some key things to think about and take note of.  There will be time for questions at the end as well.

Ed Corbett

Ed Corbett

Eversana Management Consulting

As a Senior Principal, Ed leads EVERSANA MANAGEMENT CONSULTING’s EMEA practice and has worked in the pharmaceutical industry for almost 20 years as both a consultant and pharmaceutical executive. He specializes in commercial and corporate strategy and has significant launch experience. As a pharmaceutical executive, he has personally led four launches; as a consultant, he has supported five different companies with their international launches.

Ed has supported a diverse set of clients from big pharma to biotech, helping them address a range of problems, including US entry strategy, EU launch excellence, due diligence, and portfolio optimization

Alan Crowther

Alan Crowther

Eversana Management Consulting

Alan is the General Manager of EVERSANA’s Global Pricing & Market Research group.

Alan has spent close to 20 years doing commercial work for the life sciences industry. His experience includes creating innovative solutions for global pricing and access, including work on price optimization, global data collection and analysis, and the use of advanced algorithms to support commercial decisions, including pricing.